CD19 and lung carcinoma: In lung cancer, CD45+ cells are mostly harboring lymphocyte markers CD3 and CD19 (Figures 1A,B), and the proportion of CD3+EpCAM+ cells is higher than that of CD19+EpCAM+ and CD16+EpCAM+ cells (Figures 1C,D).